Sexual dysfunction is a common adverse effect of selective serotonin reuptake inhibitors (SSRIs) and there is a concern that the sexual harms might persist after discontinuation of therapy.
OBJECTIVE:
To assess whether the use of SSRIs in animals can lead to persistent sexual dysfunction.
METHODS:
Systematic review of animal studies measuring sexual behaviour after end of treatment with SSRIs or serotonin norepinephrine reuptake inhibitors.
DATA SOURCES:
We searched PubMed and EMBASE.
RESULTS:
We included 14 studies. The general quality of the studies was poor. Only four studies reported use of randomisation and none mentioned allocation concealment. All studies used placebo and were therefore blinded. For rats exposed to SSRIs compared with those exposed to placebo, we found a higher risk of no mounting behaviour (RR = 0.73; 95% CI = 0.62–0.86), no intromission behaviour (RR = 0.74; 95% CI = 0.60–0.92) and no ejaculation behaviour (RR = 0.49, 95% CI = 0.24–1.00).
CONCLUSION:
Our results showed substantial and lasting effects on sexual behaviour in rats after exposure to an SSRI early in life on important sexual outcomes.
HealyD. Let them eat Prozac. New York University Press, 2004.
2.
GøtzschePC. Deadly Psychiatry and Organised Denial. People’s Press, 2015.
3.
RavenM. Depression and antidepressants in Australia and beyond - a critical public health analysis. Doctor of Philosophy thesis, Faculty of Arts, University of Wollongong. 2012. http://ro.uow.edu.au/thesis/3686
4.
SnoerenEMSVeeningJGOlivierBOostingRS. Serotonin 1A receptors and sexual behavior in male rats: A review. Pharmacology, Biochemistry and Behavior. 2014;121:102–14.
5.
MontejoALLlorcaGIzquierdoJALedesmaABousoñoMCalcedoACarrascoJLCiudadJDanielEGandaraJDLADerechoJFrancoMGomezMJMaciasJAMartinTPerezVSanchezJMSanchezSVicensE. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. Journal of Sex & Marital Therapy. 1997;23(3):176–94.
6.
MontejoALLlorcaGIzquierdoJARico-VillademorosF. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of outpatients. Journal of Clinical Psychiatry. 2001;62(Suppl 3):10–21.
7.
MontgomerySABaldwinDSRileyA. Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. Journal of Affective Disorders. 2002;69:119–40.
8.
CoronaGRiccaVBandiniEMannucciELottiFBoddiVRastrelliGSforzaAFaravelliCFortiGMaggiM. Selective serotonin reuptake inhibitor-induced sexual dysfunction. Journal of Sexual Medicine. 2009;6:1259–69.
9.
BregginPRBregginGR. Talking Back to Prozac. e-book. e-reads.com, 2010.
10.
MedawarC. Marketing depression and making medicines work. International Journal of Risk & Safety in Medicine. 1997;10:75–126.
11.
WilliamsVSLBaldwinDSHogueSLFehnelSEHollisKAEdinHM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: A cross-sectional patient survey. Journal of Clinical Psychiatry. 2006;67:204–10.
12.
OsváthPFeketeSVörösVVitraiJ. Sexual dysfunction among patients treated with antidepressants - a Hungarian retrospective study. European Psychiatry. 2003;18:412–4.
13.
LeeKULeeYMNamJMLeeHKKweonYSLeeCTJunTY. Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investigation. 2010;7:55–9.
14.
CsokaABBahrickAMehtonenOP. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. Journal of Sexual Medicine. 2008;5:227–33.
15.
CsokaABShipkoS. Persistent sexual side effects after SSRI discontinuation. Psychotherapy and Psychosomatics. 2006;75:187–8.
16.
HoganCLe NouryJHealyDManginD. One hundred and twenty cases of enduring sexual dysfunction following treatment. International Journal of Risk & Safety in Medicine. 2014;26:109–16.
17.
MaciagDSimpsonKLCoppingerDLuYWangYLinRCSPaulIA. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology. 2006;31(1):47–57.
18.
GouvêaTSMorimotoHKde FariaMJSSMoreiraEGGerardinDCC. Maternal exposure to the antidepressant fluoxetine impairs sexual motivation in adult male mice. Pharmacology, Biochemistry and Behavior. 2008;90:416–9.
19.
SogaTWongDWPutteerajMSongKPParharIS. Early-life citalopram-induced impairments in sexual behavior and the role of androgen receptor. Neuroscience. 2012;225:172–84.
20.
HarrisSSMaciagDSimpsonKLLinRCSPaulIA. Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Research. 2012;1429:52–60.
21.
VieiraMLHamadaRYGonzagaNIBacchiADBarbieriMMoreiraEGMesquitaSDFPGerardinDCC. Could maternal exposure to the antidepressants fluoxetine and St. John’s Wort induce long-term reproductive effects on male rats?Reproductive Toxicology. 2013;35:102–7.
22.
KilkennyCParsonsNKadyszewskiEFestingMFWCuthillICFryDHuttonJAltmanDG. Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One. 2009;4(11):e7824.
23.
KorevaarDAHooftLter RietG. Systematic reviews and meta-analyses of preclinical studies: Publication bias in laboratory animal experiments. Laboratory Animals. 2011;45:225–30.
24.
BelloSKrogsbøllLTGruberJZhaoZJFischerDHróbjartssonA. Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias. Journal of Clinical Epidemiology. 2014;67:973–83.
25.
Ritskes-HoitingaMLeenaarsMAveyMRoversMScholtenR. Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine. Cochrane database Systematic Reviews. 2014;3:ED000078.
26.
HooijmansCRRitskes-HoitingaM. Progress in using systematic reviews of animal studies to improve translational research. PLoS Medicine. 2013;10(7):e1001482.
27.
VesterinenHMSenaESEganKJHirstTCChurolovLCurrieGLAntonicAHowellsDWMacleodMR. Meta-analysis of data from animal studies: A practical guide. Journal of Neuroscience Methods. 2014;221:92–102.
28.
PetersJLSuttonAJJonesDRRushtonLAbramsKR. A Systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. Journal of Environmental Science and Health. 2006Part B;41:1245–58.
29.
HooijmansCRLeenaarsMRitskes-HoitingaM. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Alternatives to Laboratory Animals. 2010;38:167–82.
30.
KilkennyCBrowneWCuthillICEmersonMAltmanDG. Animal research: Reporting in vivo experiments - the ARRIVE guidelines. Journal of Cerebral Blood Flow & Metabolism. 2011;31:991–3.
31.
Rodriguez-PorcelFGreenDKhatriNHarrisSSMayWLLinRCSPaulIA. Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders. The Anatomical Record. 2011;294:1726–35.
32.
De JongTRSnaphaanLJAEPattijTVeeningJGWaldingerMDCoolsAROlivierB. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. European Neuropsychopharmacology. 2006;16:39–48.
33.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
34.
RayenISteinbuschHWMCharlierTDPawluskiJL. Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Psychoneuroendocrinology. 2013;38:1618–29.
35.
OlivierJDAVallèsAvan HeeschFAfrasiab-MiddelmanARoelofsJJPMJonkersMPeetersEJKorte-BouwsGAHDederenJPKiliaanAJMartensGJSchubertDHombergJR. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology. 2011;217:419–32.
36.
MaciagDWilliamsLCoppingerDPaulIA. Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. European Journal of Pharmacology. 2006;532:265–9.
37.
IñiguezSDWarrenBLBolaños-GuzmánCA. Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats. Biological Psychiatry. 2010;67(11):1057–66.
38.
CagianoRFlacePBeraIMariesLCiocaGSabatiniRBenagianoVAuteriPMarzulloAVermesanDStefanelliRAmbrosiG. Neurofunctional effects in rats prenatally exposed to fluoxetine. European Review for Medical and Pharmacological Sciences. 2008;12:137–48.
39.
MaciagDCoppingerDPaulIA. Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Research. 2006;1125:171–5.
40.
ChanJSWKimDJAhnCHOostingRSOlivierB. Clavulanic acid stimulates sexual behaviour in male rats. European Journal of Pharmacology. 2009;609:69–73.
41.
BrentDACameronJLewisDA. A primate model of the effects of childhood antidepressant treatment. American Journal of Psychiatry. 2014;171:252–5.
42.
BahrickAS. Persistence of sexual dysfunction side effects after discontinuation of antidepressant medications: Emerging evidence. The Open Psychology Journal. 2008;1:42–50.
43.
SafarinejadMRHosseiniSY. Safety and efficacy of citalopram in the treatment of premature ejaculation: A double-blind placebo-controlled, fixed dose, randomized study. International Journal of Impotence Research. 2006;18:164–9.
44.
SafarinejadMR. Safety and efficacy of escitalopram in the treatment of premature ejaculation: A double-blind, placebo-controlled, fixed-dose, randomized study. Journal of Clinical Psychopharmacology. 2007;27(5):444–50.
45.
ArafaMShamloulR. Efficacy of sertraline hydrochloride in treatment of premature ejaculation: A placebo-controlled study using a validated questionnaire. International Journal of Impotence Research. 2006;18:534–8.
46.
El-MallakhRSGaoYJeannie RobertsR. Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression. Medical Hypotheses. 2011;76:769–73.
47.
LaneRM. SSRI-Induced extrapyramidal side-effects and akathisia: Implications for treatment. Journal of Psychopharmacology. 1998;12(2):192–214.
48.
GerberPELyndLD. Selective serotonin-reuptake inhibitor - induced movement disorders. The Annals of Pharmacotherapy. 1998;32:692–8.
49.
LeeYLinPYChangYYChongMYChengAT. Antidepressant-induced tardive syndrome: A retrospective epidemiological study. Pharmacopsychiatry. 2013;46:281–5.
